Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
11 Jun, 2026, 10.31 AM IST
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
24 May, 2026, 04.23 PM IST
Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
24 May, 2026, 12.23 PM IST
Bond yields, FIIs and corporate actions among 8 factors to steer D-Street this weekNifty closed marginally higher last week, driven by IT and energy stocks, as markets brace for key events. Technical analysts suggest Nifty...
24 May, 2026, 10.23 AM IST
Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
19 May, 2026, 10.34 AM IST
Capitalmind Flexi Cap Fund exits RIL and 2 others, hikes stake in Titan Company, MCX and 16 other stocks in AprilCapitalmind Flexi Cap Fund exited Reliance Industries, Bank of Baroda, and L&T Finance in April. The fund also increased stakes in Titan Co...
15 May, 2026, 11.43 AM IST
Pharma, NBFCs see fresh mutual fund buying in AprilIndian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...
14 May, 2026, 06.26 AM IST
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
04 May, 2026, 06.00 AM IST
Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...
28 Apr, 2026, 01.17 AM IST
Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
27 Apr, 2026, 09.31 PM IST
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
20 Apr, 2026, 12.10 PM IST
CCI okays Torrent Power's proposal to acquire Nabha Power from L&T's armThe Competition Commission of India has approved Torrent Power's acquisition of Nabha Power Ltd. This deal involves Torrent Power acquiring...
07 Apr, 2026, 09.50 PM IST
Buy Torrent Pharmaceuticals, target price Rs 2250: Prabhudas LilladherTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 63896.81 Crore) operating in...
25 Oct, 2023, 10.24 AM IST
Buy Torrent Pharmaceuticals., target price Rs 2010: ICICI DirectTorrent Pharmaceuticals., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 60244.98 Crore) operating in Pha...
31 May, 2023, 12.01 PM IST
Buy Torrent Pharmaceuticals, target price Rs 1788: Sharekhan by BNP ParibasThe sales growth beat over IPM is likely to be driven by new product launches, performance of its top brands, strong growth in its newly ac...
17 Mar, 2023, 11.46 AM IST
Buy Torrent Pharmaceuticals, target price Rs 1853: ICICI SecuritiesTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 53383.00 Crore) operating in...
25 Oct, 2022, 11.03 AM IST
Buy Torrent Pharmaceuticals, target price Rs 1850: Prabhudas LilladherFor the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 2377 crore, up 8.69 per cent from last quar...
28 Sep, 2022, 12.47 PM IST